nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—DCK—Desoximetasone—Methylprednisolone—psoriatic arthritis	0.00294	0.0885	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Dexamethasone—psoriatic arthritis	0.00289	0.0871	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Betamethasone—psoriatic arthritis	0.00289	0.0871	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Methylprednisolone—psoriatic arthritis	0.00285	0.0859	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Triamcinolone—psoriatic arthritis	0.00282	0.0851	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Betamethasone—psoriatic arthritis	0.0028	0.0846	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Dexamethasone—psoriatic arthritis	0.0028	0.0846	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Triamcinolone—psoriatic arthritis	0.00274	0.0826	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Prednisone—psoriatic arthritis	0.00268	0.0808	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Prednisolone—psoriatic arthritis	0.00262	0.0789	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisone—psoriatic arthritis	0.0026	0.0784	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisolone—psoriatic arthritis	0.00254	0.0765	CbGdCrCtD
Fludarabine—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00224	0.00232	CcSEcCtD
Fludarabine—Visual disturbance—Methotrexate—psoriatic arthritis	0.00221	0.00229	CcSEcCtD
Fludarabine—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00221	0.00228	CcSEcCtD
Fludarabine—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.0022	0.00228	CcSEcCtD
Fludarabine—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00219	0.00227	CcSEcCtD
Fludarabine—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00219	0.00226	CcSEcCtD
Fludarabine—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00219	0.00226	CcSEcCtD
Fludarabine—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00219	0.00226	CcSEcCtD
Fludarabine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00218	0.00225	CcSEcCtD
Fludarabine—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00217	0.00225	CcSEcCtD
Fludarabine—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00217	0.00225	CcSEcCtD
Fludarabine—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00217	0.00225	CcSEcCtD
Fludarabine—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00217	0.00225	CcSEcCtD
Fludarabine—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00214	0.00221	CcSEcCtD
Fludarabine—Arrhythmia—Prednisolone—psoriatic arthritis	0.00213	0.0022	CcSEcCtD
Fludarabine—Sweating increased—Prednisone—psoriatic arthritis	0.00211	0.00218	CcSEcCtD
Fludarabine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00211	0.00218	CcSEcCtD
Fludarabine—Neutropenia—Prednisone—psoriatic arthritis	0.00203	0.0021	CcSEcCtD
Fludarabine—Haemoglobin—Dexamethasone—psoriatic arthritis	0.002	0.00207	CcSEcCtD
Fludarabine—Haemoglobin—Betamethasone—psoriatic arthritis	0.002	0.00207	CcSEcCtD
Fludarabine—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00199	0.00206	CcSEcCtD
Fludarabine—Haemorrhage—Betamethasone—psoriatic arthritis	0.00199	0.00206	CcSEcCtD
Fludarabine—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00196	0.00203	CcSEcCtD
Fludarabine—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00196	0.00202	CcSEcCtD
Fludarabine—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00195	0.00202	CcSEcCtD
Fludarabine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00193	0.002	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00193	0.00199	CcSEcCtD
Fludarabine—Visual impairment—Dexamethasone—psoriatic arthritis	0.00192	0.00198	CcSEcCtD
Fludarabine—Visual impairment—Betamethasone—psoriatic arthritis	0.00192	0.00198	CcSEcCtD
Fludarabine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00191	0.00197	CcSEcCtD
Fludarabine—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.0019	0.00197	CcSEcCtD
Fludarabine—Myocardial infarction—Prednisone—psoriatic arthritis	0.00189	0.00196	CcSEcCtD
Fludarabine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00189	0.00196	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00189	0.00195	CcSEcCtD
Fludarabine—Malaise—Prednisolone—psoriatic arthritis	0.00187	0.00194	CcSEcCtD
Fludarabine—Convulsion—Prednisolone—psoriatic arthritis	0.0018	0.00186	CcSEcCtD
Fludarabine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00178	0.00184	CcSEcCtD
Fludarabine—Arrhythmia—Betamethasone—psoriatic arthritis	0.00178	0.00184	CcSEcCtD
Fludarabine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00177	0.00183	CcSEcCtD
Fludarabine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00177	0.00183	CcSEcCtD
Fludarabine—Alopecia—Dexamethasone—psoriatic arthritis	0.00176	0.00182	CcSEcCtD
Fludarabine—Alopecia—Betamethasone—psoriatic arthritis	0.00176	0.00182	CcSEcCtD
Fludarabine—Discomfort—Prednisolone—psoriatic arthritis	0.00175	0.00181	CcSEcCtD
Fludarabine—Haemoglobin—Prednisone—psoriatic arthritis	0.00174	0.0018	CcSEcCtD
Fludarabine—Haemorrhage—Prednisone—psoriatic arthritis	0.00173	0.00179	CcSEcCtD
Fludarabine—Malaise—Triamcinolone—psoriatic arthritis	0.00172	0.00178	CcSEcCtD
Fludarabine—Pancytopenia—Methotrexate—psoriatic arthritis	0.00172	0.00178	CcSEcCtD
Fludarabine—Malaise—Methylprednisolone—psoriatic arthritis	0.00172	0.00178	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.0017	0.00175	CcSEcCtD
Fludarabine—Oedema—Prednisolone—psoriatic arthritis	0.0017	0.00175	CcSEcCtD
Fludarabine—Dysuria—Methotrexate—psoriatic arthritis	0.00169	0.00175	CcSEcCtD
Fludarabine—Neutropenia—Methotrexate—psoriatic arthritis	0.00169	0.00175	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00168	0.00174	CcSEcCtD
Fludarabine—Cough—Triamcinolone—psoriatic arthritis	0.00167	0.00172	CcSEcCtD
Fludarabine—Convulsion—Triamcinolone—psoriatic arthritis	0.00166	0.00171	CcSEcCtD
Fludarabine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00165	0.00171	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00164	0.0017	CcSEcCtD
Fludarabine—Myalgia—Triamcinolone—psoriatic arthritis	0.00163	0.00168	CcSEcCtD
Fludarabine—Pneumonia—Methotrexate—psoriatic arthritis	0.00162	0.00168	CcSEcCtD
Fludarabine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00162	0.00168	CcSEcCtD
Fludarabine—Myalgia—Methylprednisolone—psoriatic arthritis	0.00162	0.00168	CcSEcCtD
Fludarabine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00161	0.00166	CcSEcCtD
Fludarabine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00161	0.00166	CcSEcCtD
Fludarabine—Discomfort—Triamcinolone—psoriatic arthritis	0.00161	0.00166	CcSEcCtD
Fludarabine—Discomfort—Methylprednisolone—psoriatic arthritis	0.0016	0.00166	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.0016	0.00166	CcSEcCtD
Fludarabine—Renal failure—Methotrexate—psoriatic arthritis	0.00159	0.00164	CcSEcCtD
Fludarabine—Stomatitis—Methotrexate—psoriatic arthritis	0.00157	0.00163	CcSEcCtD
Fludarabine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00157	0.00162	CcSEcCtD
Fludarabine—Malaise—Dexamethasone—psoriatic arthritis	0.00156	0.00162	CcSEcCtD
Fludarabine—Malaise—Betamethasone—psoriatic arthritis	0.00156	0.00162	CcSEcCtD
Fludarabine—Oedema—Triamcinolone—psoriatic arthritis	0.00156	0.00161	CcSEcCtD
Fludarabine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00156	0.00161	CcSEcCtD
Fludarabine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00156	0.00161	CcSEcCtD
Fludarabine—Arrhythmia—Prednisone—psoriatic arthritis	0.00155	0.0016	CcSEcCtD
Fludarabine—Infection—Triamcinolone—psoriatic arthritis	0.00155	0.0016	CcSEcCtD
Fludarabine—Infection—Methylprednisolone—psoriatic arthritis	0.00155	0.0016	CcSEcCtD
Fludarabine—Haematuria—Methotrexate—psoriatic arthritis	0.00154	0.00159	CcSEcCtD
Fludarabine—Alopecia—Prednisone—psoriatic arthritis	0.00153	0.00158	CcSEcCtD
Fludarabine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00153	0.00158	CcSEcCtD
Fludarabine—Epistaxis—Methotrexate—psoriatic arthritis	0.00152	0.00157	CcSEcCtD
Fludarabine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00152	0.00157	CcSEcCtD
Fludarabine—Malnutrition—Prednisone—psoriatic arthritis	0.00151	0.00156	CcSEcCtD
Fludarabine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00151	0.00156	CcSEcCtD
Fludarabine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.0015	0.00156	CcSEcCtD
Fludarabine—Convulsion—Dexamethasone—psoriatic arthritis	0.0015	0.00155	CcSEcCtD
Fludarabine—Convulsion—Betamethasone—psoriatic arthritis	0.0015	0.00155	CcSEcCtD
Fludarabine—Myalgia—Dexamethasone—psoriatic arthritis	0.00148	0.00153	CcSEcCtD
Fludarabine—Myalgia—Betamethasone—psoriatic arthritis	0.00148	0.00153	CcSEcCtD
Fludarabine—Discomfort—Betamethasone—psoriatic arthritis	0.00146	0.00151	CcSEcCtD
Fludarabine—Discomfort—Dexamethasone—psoriatic arthritis	0.00146	0.00151	CcSEcCtD
Fludarabine—Haemoglobin—Methotrexate—psoriatic arthritis	0.00146	0.00151	CcSEcCtD
Fludarabine—Pain—Prednisolone—psoriatic arthritis	0.00145	0.0015	CcSEcCtD
Fludarabine—Haemorrhage—Methotrexate—psoriatic arthritis	0.00145	0.0015	CcSEcCtD
Fludarabine—Pharyngitis—Methotrexate—psoriatic arthritis	0.00144	0.00149	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00142	0.00147	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00142	0.00147	CcSEcCtD
Fludarabine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00141	0.00146	CcSEcCtD
Fludarabine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00141	0.00146	CcSEcCtD
Fludarabine—Oedema—Betamethasone—psoriatic arthritis	0.00141	0.00146	CcSEcCtD
Fludarabine—Oedema—Dexamethasone—psoriatic arthritis	0.00141	0.00146	CcSEcCtD
Fludarabine—Infection—Dexamethasone—psoriatic arthritis	0.00141	0.00145	CcSEcCtD
Fludarabine—Infection—Betamethasone—psoriatic arthritis	0.00141	0.00145	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.0014	0.00145	CcSEcCtD
Fludarabine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.0014	0.00145	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.0014	0.00145	CcSEcCtD
Fludarabine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.0014	0.00144	CcSEcCtD
Fludarabine—Visual impairment—Methotrexate—psoriatic arthritis	0.0014	0.00144	CcSEcCtD
Fludarabine—Anaemia—Prednisone—psoriatic arthritis	0.0014	0.00144	CcSEcCtD
Fludarabine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00139	0.00144	CcSEcCtD
Fludarabine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00139	0.00143	CcSEcCtD
Fludarabine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00139	0.00143	CcSEcCtD
Fludarabine—Agitation—Prednisone—psoriatic arthritis	0.00139	0.00143	CcSEcCtD
Fludarabine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00139	0.00143	CcSEcCtD
Fludarabine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00139	0.00143	CcSEcCtD
Fludarabine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00137	0.00142	CcSEcCtD
Fludarabine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00137	0.00142	CcSEcCtD
Fludarabine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00137	0.00142	CcSEcCtD
Fludarabine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00137	0.00141	CcSEcCtD
Fludarabine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00137	0.00141	CcSEcCtD
Fludarabine—Malaise—Prednisone—psoriatic arthritis	0.00136	0.00141	CcSEcCtD
Fludarabine—Anorexia—Dexamethasone—psoriatic arthritis	0.00135	0.00139	CcSEcCtD
Fludarabine—Anorexia—Betamethasone—psoriatic arthritis	0.00135	0.00139	CcSEcCtD
Fludarabine—Fatigue—Triamcinolone—psoriatic arthritis	0.00134	0.00139	CcSEcCtD
Fludarabine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00134	0.00139	CcSEcCtD
Fludarabine—Pain—Triamcinolone—psoriatic arthritis	0.00133	0.00138	CcSEcCtD
Fludarabine—Convulsion—Prednisone—psoriatic arthritis	0.00131	0.00135	CcSEcCtD
Fludarabine—Chills—Methotrexate—psoriatic arthritis	0.0013	0.00134	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00129	0.00133	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00129	0.00133	CcSEcCtD
Fludarabine—Myalgia—Prednisone—psoriatic arthritis	0.00129	0.00133	CcSEcCtD
Fludarabine—Arthralgia—Prednisone—psoriatic arthritis	0.00129	0.00133	CcSEcCtD
Fludarabine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00128	0.00133	CcSEcCtD
Fludarabine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00128	0.00133	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—psoriatic arthritis	0.00128	0.00132	CcSEcCtD
Fludarabine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00127	0.00131	CcSEcCtD
Fludarabine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00127	0.00131	CcSEcCtD
Fludarabine—Discomfort—Prednisone—psoriatic arthritis	0.00127	0.00131	CcSEcCtD
Fludarabine—Malnutrition—Methotrexate—psoriatic arthritis	0.00126	0.0013	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00125	0.00129	CcSEcCtD
Fludarabine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00125	0.00129	CcSEcCtD
Fludarabine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00125	0.00129	CcSEcCtD
Fludarabine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00123	0.00127	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00123	0.00127	CcSEcCtD
Fludarabine—Oedema—Prednisone—psoriatic arthritis	0.00123	0.00127	CcSEcCtD
Fludarabine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00123	0.00127	CcSEcCtD
Fludarabine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00123	0.00127	CcSEcCtD
Fludarabine—Infection—Prednisone—psoriatic arthritis	0.00122	0.00127	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00122	0.00126	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00122	0.00126	CcSEcCtD
Fludarabine—Fatigue—Dexamethasone—psoriatic arthritis	0.00122	0.00126	CcSEcCtD
Fludarabine—Fatigue—Betamethasone—psoriatic arthritis	0.00122	0.00126	CcSEcCtD
Fludarabine—Pain—Dexamethasone—psoriatic arthritis	0.00121	0.00125	CcSEcCtD
Fludarabine—Pain—Betamethasone—psoriatic arthritis	0.00121	0.00125	CcSEcCtD
Fludarabine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00121	0.00125	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00119	0.00123	CcSEcCtD
Fludarabine—Anorexia—Prednisone—psoriatic arthritis	0.00117	0.00121	CcSEcCtD
Fludarabine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00117	0.00121	CcSEcCtD
Fludarabine—Anaemia—Methotrexate—psoriatic arthritis	0.00117	0.00121	CcSEcCtD
Fludarabine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00117	0.00121	CcSEcCtD
Fludarabine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00117	0.00121	CcSEcCtD
Fludarabine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00115	0.00119	CcSEcCtD
Fludarabine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00115	0.00119	CcSEcCtD
Fludarabine—Malaise—Methotrexate—psoriatic arthritis	0.00114	0.00118	CcSEcCtD
Fludarabine—Leukopenia—Methotrexate—psoriatic arthritis	0.00113	0.00117	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00112	0.00116	CcSEcCtD
Fludarabine—Asthenia—Triamcinolone—psoriatic arthritis	0.00112	0.00116	CcSEcCtD
Fludarabine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00112	0.00116	CcSEcCtD
Fludarabine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00112	0.00116	CcSEcCtD
Fludarabine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00112	0.00115	CcSEcCtD
Fludarabine—Paraesthesia—Prednisone—psoriatic arthritis	0.00111	0.00114	CcSEcCtD
Fludarabine—Pruritus—Triamcinolone—psoriatic arthritis	0.0011	0.00114	CcSEcCtD
Fludarabine—Cough—Methotrexate—psoriatic arthritis	0.0011	0.00114	CcSEcCtD
Fludarabine—Pruritus—Methylprednisolone—psoriatic arthritis	0.0011	0.00114	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—psoriatic arthritis	0.00109	0.00113	CcSEcCtD
Fludarabine—Dyspepsia—Prednisone—psoriatic arthritis	0.00108	0.00112	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Fludarabine—Arthralgia—Methotrexate—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Fludarabine—Decreased appetite—Prednisone—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Fludarabine—Rash—Prednisolone—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Fludarabine—Dermatitis—Prednisolone—psoriatic arthritis	0.00107	0.0011	CcSEcCtD
Fludarabine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00106	0.0011	CcSEcCtD
Fludarabine—Fatigue—Prednisone—psoriatic arthritis	0.00106	0.0011	CcSEcCtD
Fludarabine—Headache—Prednisolone—psoriatic arthritis	0.00106	0.0011	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—psoriatic arthritis	0.00106	0.0011	CcSEcCtD
Fludarabine—Constipation—Prednisone—psoriatic arthritis	0.00105	0.00109	CcSEcCtD
Fludarabine—Confusional state—Methotrexate—psoriatic arthritis	0.00104	0.00107	CcSEcCtD
Fludarabine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00103	0.00106	CcSEcCtD
Fludarabine—Infection—Methotrexate—psoriatic arthritis	0.00102	0.00106	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00102	0.00105	CcSEcCtD
Fludarabine—Asthenia—Betamethasone—psoriatic arthritis	0.00101	0.00105	CcSEcCtD
Fludarabine—Asthenia—Dexamethasone—psoriatic arthritis	0.00101	0.00105	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00101	0.00104	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00101	0.00104	CcSEcCtD
Fludarabine—Nausea—Prednisolone—psoriatic arthritis	0.00101	0.00104	CcSEcCtD
Fludarabine—Pruritus—Dexamethasone—psoriatic arthritis	0.001	0.00104	CcSEcCtD
Fludarabine—Pruritus—Betamethasone—psoriatic arthritis	0.001	0.00104	CcSEcCtD
Fludarabine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000995	0.00103	CcSEcCtD
Fludarabine—Vomiting—Triamcinolone—psoriatic arthritis	0.000991	0.00103	CcSEcCtD
Fludarabine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000989	0.00102	CcSEcCtD
Fludarabine—Rash—Triamcinolone—psoriatic arthritis	0.000983	0.00102	CcSEcCtD
Fludarabine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000982	0.00102	CcSEcCtD
Fludarabine—Anorexia—Methotrexate—psoriatic arthritis	0.000981	0.00102	CcSEcCtD
Fludarabine—Rash—Methylprednisolone—psoriatic arthritis	0.000981	0.00101	CcSEcCtD
Fludarabine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00098	0.00101	CcSEcCtD
Fludarabine—Headache—Triamcinolone—psoriatic arthritis	0.000977	0.00101	CcSEcCtD
Fludarabine—Headache—Methylprednisolone—psoriatic arthritis	0.000975	0.00101	CcSEcCtD
Fludarabine—Body temperature increased—Prednisone—psoriatic arthritis	0.000974	0.00101	CcSEcCtD
Fludarabine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000968	0.001	CcSEcCtD
Fludarabine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000968	0.001	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000938	0.00097	CcSEcCtD
Fludarabine—Nausea—Triamcinolone—psoriatic arthritis	0.000926	0.000958	CcSEcCtD
Fludarabine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000925	0.000956	CcSEcCtD
Fludarabine—Nausea—Methylprednisolone—psoriatic arthritis	0.000924	0.000956	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000918	0.000949	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000908	0.000939	CcSEcCtD
Fludarabine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000906	0.000937	CcSEcCtD
Fludarabine—Vomiting—Dexamethasone—psoriatic arthritis	0.000899	0.00093	CcSEcCtD
Fludarabine—Vomiting—Betamethasone—psoriatic arthritis	0.000899	0.00093	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000895	0.000926	CcSEcCtD
Fludarabine—Rash—Dexamethasone—psoriatic arthritis	0.000892	0.000923	CcSEcCtD
Fludarabine—Rash—Betamethasone—psoriatic arthritis	0.000892	0.000923	CcSEcCtD
Fludarabine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000891	0.000922	CcSEcCtD
Fludarabine—Dermatitis—Betamethasone—psoriatic arthritis	0.000891	0.000922	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000889	0.000919	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—psoriatic arthritis	0.000888	0.000918	CcSEcCtD
Fludarabine—Headache—Dexamethasone—psoriatic arthritis	0.000886	0.000917	CcSEcCtD
Fludarabine—Headache—Betamethasone—psoriatic arthritis	0.000886	0.000917	CcSEcCtD
Fludarabine—Asthenia—Prednisone—psoriatic arthritis	0.000884	0.000914	CcSEcCtD
Fludarabine—Pain—Methotrexate—psoriatic arthritis	0.00088	0.000911	CcSEcCtD
Fludarabine—Pruritus—Prednisone—psoriatic arthritis	0.000872	0.000902	CcSEcCtD
Fludarabine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000848	0.000878	CcSEcCtD
Fludarabine—Diarrhoea—Prednisone—psoriatic arthritis	0.000843	0.000872	CcSEcCtD
Fludarabine—Nausea—Dexamethasone—psoriatic arthritis	0.00084	0.000869	CcSEcCtD
Fludarabine—Nausea—Betamethasone—psoriatic arthritis	0.00084	0.000869	CcSEcCtD
Fludarabine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000814	0.000842	CcSEcCtD
Fludarabine—Vomiting—Prednisone—psoriatic arthritis	0.000783	0.00081	CcSEcCtD
Fludarabine—Rash—Prednisone—psoriatic arthritis	0.000777	0.000803	CcSEcCtD
Fludarabine—Dermatitis—Prednisone—psoriatic arthritis	0.000776	0.000803	CcSEcCtD
Fludarabine—Headache—Prednisone—psoriatic arthritis	0.000772	0.000798	CcSEcCtD
Fludarabine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000759	0.000785	CcSEcCtD
Fludarabine—Asthenia—Methotrexate—psoriatic arthritis	0.000739	0.000764	CcSEcCtD
Fludarabine—Nausea—Prednisone—psoriatic arthritis	0.000732	0.000757	CcSEcCtD
Fludarabine—Pruritus—Methotrexate—psoriatic arthritis	0.000728	0.000753	CcSEcCtD
Fludarabine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000704	0.000729	CcSEcCtD
Fludarabine—Vomiting—Methotrexate—psoriatic arthritis	0.000655	0.000677	CcSEcCtD
Fludarabine—Rash—Methotrexate—psoriatic arthritis	0.000649	0.000671	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—psoriatic arthritis	0.000649	0.000671	CcSEcCtD
Fludarabine—Headache—Methotrexate—psoriatic arthritis	0.000645	0.000667	CcSEcCtD
Fludarabine—Nausea—Methotrexate—psoriatic arthritis	0.000612	0.000633	CcSEcCtD
